Yahoo Web Search

  1. Related topics

    small business growth
    • Small Business | The Tribune

      The Ironton Tribune· 1 hour ago

      Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that a new analysis of results from the SOLOIST-WHF Phase 3 outcomes trial of sotagliflozin, an investigational dual SGLT1 and SGLT2 ...